Double-blind Switch Study of Imipramine or Sertraline Treatment of Antidepressant-Resistant Chronic Depression
Michael E. Thase(Veterans Health Administration), Wilma Harrison(Pfizer (United States)), Robert H. Howland(University of Pittsburgh), Lisa M. LaVange(University of North Carolina at Chapel Hill), Daniel N. Klein(Stony Brook University), Alan F. Schatzberg(Stanford University), Susan G. Kornstein(Virginia Commonwealth University), Alan J. Gelenberg(University of Arizona), James M. Russell(The University of Texas Medical Branch at Galveston), James H. Kocsis(Cornell University), Robert M. A. Hirschfeld(The University of Texas Medical Branch at Galveston), Martín Keller(University of Basel), Jan Fawcett, A. John Rush(The University of Texas Southwestern Medical Center)
Cited by 146
Related Papers
The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
|Biological Psychiatry|2003|3.9k
Lifetime and 12-Month Prevalence of Bipolar Spectrum Disorder in the National Comorbidity Survey Replication
|Archives of General Psychiatry|2007|2.4k
Resting-state connectivity biomarkers define neurophysiological subtypes of depression
|Nature Medicine|2016|2.2k
Major depressive disorder
|Nature Reviews Disease Primers|2016|2.1k
A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression
|New England Journal of Medicine|2000|1.3k